The neuroprotection of oxymatrine in cerebral ischemia/reperfusion is related to nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated antioxidant response: Role of Nrf2 and hemeoxygenase-1 expression

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 5, 2011, Pages 595-601

  Li, Min ^a   Zhang, Xiangjian ^a   Cui, Lili ^a   Yang, Rui ^a   Wang, Lina ^a   Liu, Lingling ^a   Du, Wei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia reperfusion; Hemeoxygenase 1; Neuroprotection; Nuclear factor erythroid 2 related factor 2; Oxymatrine

Indexed keywords

HEME OXYGENASE 1; OXYMATRINE; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN EDEMA; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN WATER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; UPREGULATION; WESTERN BLOTTING;

ALKALOIDS; ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; BRAIN ISCHEMIA; HEME OXYGENASE-1; IMMUNOHISTOCHEMISTRY; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 79955645935     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.595     Document Type: Article

References (34)

1. Donnan G. A., Fisher M., Macleod M., Davis S. M., Lancet, 371, 1612-1623 (2008).
2. Winquist R. J., Kerr S., Neurology, 49, S23-S26 (1997).
3. Patt A., Rutherford R. B., Pearce W. H., Repine J. E., J. Surg. Res., 42, 462-466 (1987).
4. Patt A., Harken A. H., Burton L. K., Rodell T. C., Piermattei D., Schorr W. J., Parker N. B., Berger E. M., Horesh I. R., Terada L. S., Linas S. L., Cheronis J. C., Repine J. E., J. Clin. Invest., 81, 1556-1562 (1988).
5. Christophe M., Nicolas S., Curr. Pharm. Des., 12, 739-757 (2006).
6. Nakka V. P., Gusain A., Mehta S. L., Raghubir R., Mol. Neurobiol., 37, 7-38 (2008).
7. Cuzzocrea S., Riley D. P., Caputi A. P., Salvemini D., Pharmacol. Rev., 53, 135-159 (2001).
8. Lakhan S. E., Kirchgessner A., Hofer M., J. Transl. Med., 7, 97 (2009).
9. Granger D. N., Hollwarth M. E., Parkes D. A., Acta Physiol. Scand., 548, 47-63 (1986).
10. Chan P. H., J. Cereb. Blood Flow Metab., 21, 2-14 (2001).
11. Sugawara T., Chan P. H., Antioxid. Redox. Signal., 5, 597-607 (2003).
12. Yoshida T., Watanabe M., Engelman D. T., Engelman R. M., Schley J. A., Maulik N., Ho Y. S., Oberley T. D., Das D. K., J. Mol. Cell. Cardiol., 28, 1759-1767 (1996).
13. Chan P. H., Stroke, 27, 1124-1129 (1996).
14. Keller J. N., Kindy M. S., Holtsberg F. W., St Clair D. K., Yen H. C., Germeyer A., Steiner S. M., Bruce-Keller A. J., Hutchins J. B., Mattson M. P., J. Neurosci., 18, 687-697 (1998).
15. Kawase M., Murakami K., Fujimura M., Morita-Fujimura Y., Gasche Y., Kondo T., Scott R. W., Chan P. H., Stroke, 30, 1962-1968 (1999).
16. Itoh K., Mochizuki M., Ishii Y., Ishii T., Shibata T., Kawamoto Y., Kelly V., Sekizawa K., Uchida K., Yamamoto M., Mol. Cell. Biol., 24, 36-45 (2004).
17. Gong P., Stewart D., Hu B., Li N., Cook J., Nel A., Alam J., Antioxid. Redox. Signal., 4, 249-257 (2002).
18. Chan J. Y., Kwong M., Biochim. Biophys. Acta, 1517, 19-26 (2000).
19. Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S., Yamamoto M., J. Biol. Chem., 275, 16023-16029 (2000).
20. Fu R., Zhao Z. Q., Zhao H. Y., Zhao J. S., Zhu X. L., Neurol. Res., 28, 38-45 (2006).
21. Shih A. Y., Li P., Murphy T. H., J. Neurosci., 25, 10321-10335 (2005).
22. Maines M. D., Panahian N., Adv. Exp. Med. Biol., 502, 249-272 (2001).
23. Poss K. D., Tonegawa S., Proc. Natl. Acad. Sci. U.S.A., 94, 10925-10930 (1997).
24. Lee J. M., Calkins M. J., Chan K., Kan Y. W., Johnson J. A., J. Biol. Chem., 278, 12029-12038 (2003).
25. Kraft A. D., Johnson D. A., Johnson J. A., J. Neurosci., 24, 1101-1112 (2004).
26. Yang C., Zhang X., Fan H., Liu Y., Brain Res., 1282, 133-141 (2009).
27. Fan H., Li L., Zhang X., Liu Y., Yang C., Yang Y., Yin J., Mediators Inflamm., 2009, 704-706 (2009).
28. Longa E. Z., Weinstein P. R., Carlson S., Cummins R., Stroke, 20, 84-91 (1989).
29. Tatlisumak T., Carano R. A., Takano K., Opgenorth T. J., Sotak C. H., Fisher M., Stroke, 29, 850-857 (1998).
30. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J. D., Yamamoto M., Genes Dev., 13, 76-86 (1999).
31. Coyle J. T., Puttfarcken P., Science, 262, 689-695 (1993).
32. Lipton P., Physiol. Rev., 79, 1431-568 (1999).
33. Satoh T., Okamoto S. I., Cui J., Watanabe Y., Furuta K., Suzuki M., Tohyama K., Lipton S. A., Proc. Natl. Acad. Sci. U.S.A., 103, 768-773 (2006).
34. Liu Y., Zhang X. J., Yang C. H., Fan H. G., Brain Res., 1268, 174-180 (2009).